These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
252 related articles for article (PubMed ID: 30965082)
1. Design, computational studies, synthesis and biological evaluation of thiazole-based molecules as anticancer agents. Anuradha ; Patel S; Patle R; Parameswaran P; Jain A; Shard A Eur J Pharm Sci; 2019 Jun; 134():20-30. PubMed ID: 30965082 [TBL] [Abstract][Full Text] [Related]
2. A New Series of Antileukemic Agents: Design, Synthesis, In Vitro and In Silico Evaluation of Thiazole-Based ABL1 Kinase Inhibitors. Zeytün E; Altıntop MD; Sever B; Özdemir A; Ellakwa DE; Ocak Z; Ciftci HI; Otsuka M; Fujita M; Radwan MO Anticancer Agents Med Chem; 2021; 21(9):1099-1109. PubMed ID: 32838725 [TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis, and Evaluation of a New Series of Thiazole-Based Anticancer Agents as Potent Akt Inhibitors. Altıntop MD; Sever B; Akalın Çiftçi G; Özdemir A Molecules; 2018 May; 23(6):. PubMed ID: 29857484 [TBL] [Abstract][Full Text] [Related]
4. Thiazole-Chalcone Hybrids as Prospective Antitubercular and Antiproliferative Agents: Design, Synthesis, Biological, Molecular Docking Studies and In Silico ADME Evaluation. Kasetti AB; Singhvi I; Nagasuri R; Bhandare RR; Shaik AB Molecules; 2021 May; 26(10):. PubMed ID: 34064806 [TBL] [Abstract][Full Text] [Related]
5. Chemical Characterization, Ansari JA; Ahmad MK; Fatima N; Azad I; Mahdi AA; Satyanarayan GNV; Ahmad N Anticancer Agents Med Chem; 2022; 22(20):3416-3437. PubMed ID: 35125087 [TBL] [Abstract][Full Text] [Related]
6. A new series of thiazole-hydrazone hybrids for Akt-targeted therapy of non-small cell lung cancer. Orujova T; Ece A; Akalın Çiftçi G; Özdemir A; Altıntop MD Drug Dev Res; 2023 Apr; 84(2):185-199. PubMed ID: 36469421 [TBL] [Abstract][Full Text] [Related]
7. Exploring the novel heterocyclic derivatives as lead molecules for design and development of potent anticancer agents. Azad I; Nasibullah M; Khan T; Hassan F; Akhter Y J Mol Graph Model; 2018 May; 81():211-228. PubMed ID: 29609141 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, Cytotoxicity Evaluation, Molecular Docking and Utility of Novel Chalcones as Precursors for Heterocycles Incorporating Pyrazole Moiety. Gomha SM; Abdallah MA; Abbas IM; Kazem MSH Med Chem; 2018; 14(4):344-355. PubMed ID: 29065841 [TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationship studies of ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (HA 14-1), an antagonist for antiapoptotic Bcl-2 proteins to overcome drug resistance in cancer. Doshi JM; Tian D; Xing C J Med Chem; 2006 Dec; 49(26):7731-9. PubMed ID: 17181155 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and Biological Evaluation of Novel Heterocyclic Imines Linked Coumarin- Thiazole Hybrids as Anticancer Agents. Goud NS; Ghouse MS; Vishnu J; Pranay J; Alvala R; Talla V; Qureshi IA; Alvala M Anticancer Agents Med Chem; 2019; 19(4):557-566. PubMed ID: 30734685 [TBL] [Abstract][Full Text] [Related]
11. Anticancer activity of newly synthesized 1,1-disubstituted cyclohexane-1-carboxamides: in vitro caspases mediated apoptosis activators in human cancer cell lines and their molecular modeling. Abd-Allah WH; Salman A; Sabry Saad S Drug Dev Res; 2019 Nov; 80(7):933-947. PubMed ID: 31343754 [TBL] [Abstract][Full Text] [Related]